研究等業績 - その他 - 尾野 祐一
-
特集 透析患者の骨粗鬆症と骨折を理解する 3.骨粗鬆症の診断(3)骨折を伴わない・伴う骨粗鬆症の画像診断
尾野 祐一, 宮腰 尚久
臨床透析 ( 日本メディカルセンター ) 41 ( 3 ) 260 - 267 2025年03月
-
連載 最新原著レビュー 神経根ブロックにおける超音波ガイド下と透視・CTガイド下の有効性の比較
木村 竜太, 山本 乃利男, 渡部 純, 尾野 祐一, 本郷 道生, 宮腰 尚久
整形外科 ( 南江堂 ) 76 ( 3 ) 267 - 271 2025年03月
-
Okamoto K.
Applied Sciences (Switzerland) ( Applied Sciences (Switzerland) ) 14 ( 19 ) 2024年10月
-
Kimura R.
European Spine Journal ( European Spine Journal ) 33 ( 7 ) 2929 - 2930 2024年07月
-
Kimura R.
European Spine Journal ( European Spine Journal ) 32 ( 12 ) 4101 - 4110 2023年12月
-
Association of the Bioimpedance Phase Angle and Quality of Life in Postmenopausal Osteoporosis
Ono Y.
Medical Principles and Practice ( Medical Principles and Practice ) 32 ( 1 ) 71 - 76 2023年06月
-
Hatakeyama Y.
Acta Medica Okayama ( Acta Medica Okayama ) 77 ( 5 ) 499 - 509 2023年
-
Chronic atlantoaxial rotatory fixation with neurofibromatosis type I: A case report
Ono Y.
Surgical Neurology International ( Surgical Neurology International ) 13 2022年
-
Evaluation of the Nature and Etiologies of Risk Factors for Diaphyseal Atypical Femoral Fractures
Tsuchie H.
Medical Principles and Practice ( Medical Principles and Practice ) 30 ( 5 ) 430 - 436 2021年10月
-
Tsuchie H.
Bone ( Bone ) 143 2021年02月
-
Growing Rod Surgery for Early-Onset Scoliosis in an Osteogenesis Imperfecta Patient
Ono Y.
World Neurosurgery ( World Neurosurgery ) 144 178 - 183 2020年12月
-
Yuasa Y.
Journal of Bone and Mineral Metabolism ( Journal of Bone and Mineral Metabolism ) 38 ( 2 ) 179 - 187 2020年03月
-
Diagnosis of presarcopenia using body height and arm span for postmenopausal osteoporosis
Ono Y.
Clinical Interventions in Aging ( Clinical Interventions in Aging ) 15 357 - 361 2020年
-
Pigmented Villonodular Synovitis Around the Elbow Joint That Required Upper Arm Amputation
Ono Y.
Journal of Medical Cases ( Journal of Medical Cases ) 11 ( 7 ) 201 - 203 2020年
-
Kasukawa Yuji, Miyakoshi Naohisa, Hongo Michio, Ishikawa Yoshinori, Kudo Daisuke, Kimura Ryota, Ono Yuichi, Shimada Yoichi
Progress in Rehabilitation Medicine ( 公益社団法人 日本リハビリテーション医学会 ) 5 ( 0 ) n/a 2020年
<p><b>Objectives: </b>The extent to which locomotive syndrome is associated with low back pain (LBP), health-related quality of life (HRQOL), and impairment of activities of daily living among elderly men and women remains poorly documented. This study evaluated associations between locomotive syndrome and both HRQOL and LBP as assessed using a questionnaire completed by elderly individuals, including some >80 years old.</p><p><b>Methods: </b>We conducted a survey assessing locomotive syndrome using the loco-check, HRQOL using the Short-Form 36 questionnaire (SF-36), and LBP using the Roland-Morris Disability Questionnaire (RDQ) among individuals >60 years old. SF-36 and RDQ scores were compared between 253 subjects with and without locomotive syndrome.</p><p><b>Results: </b>Fifty-seven men (48%) and 71 women (53%) were diagnosed with locomotive syndrome. Subjects of both sexes with locomotive syndrome scored significantly lower for eight items from SF-36. Physical and mental component summary scores were significantly worse in women with locomotive syndrome in their 60s and 70s. RDQ scores were significantly higher in participants with locomotive syndrome for men in their 60s and for both men and women in their 70s.</p><p><b>Conclusions: </b>Locomotive syndrome was associated with impaired HRQOL and worse LBP among men and women >60 years old. Differences in HRQOL and LBP between subjects with and without locomotive syndrome were significant for both men and women in their 60s and 70s, but not in their 80s. Locomotive syndrome should be prevented to maintain HRQOL, particularly for men and women in their 60s and 70s.</p>
-
Ono Y.
Biomedical Research (Japan) ( Biomedical Research (Japan) ) 40 ( 5 ) 197 - 205 2019年
<p>We investigated the effects of ibandronate, a bisphosphonate; eldecalcitol, an active vitamin D3 analogue; and combination treatment with both agents on secondary osteoporosis and arthritis using rats with adjuvant-induced arthritis. Arthritis was induced in 8-week-old male Lewis rats. Rats were randomized into four treatment groups and an untreated normal control group: ibandronate, eldecalcitol, ibandronate + eldecalcitol, vehicle, and control. Paw thickness was measured to evaluate arthritis. Joint destruction was evaluated histomorphometrically by the ankle joint stained with Fast Green and safranin O. The femur and lumbar spine were scanned using dual-energy X-ray absorptiometry, and the distal femur was scanned using micro-computed tomography for bone mineral density (BMD) and trabecular microstructural evaluations. Ibandronate and/or eldecalcitol increased BMD in both the lumbar vertebrae and femur and improved several microstructural parameters (bone volume/total volume, structure model index, trabecular number, and trabecular separation of the distal femur). In addition, there was an additive effect of combination treatment compared with single treatments for most trabecular parameters, including BMD and bone volume. However, ibandronate and/or eldecalcitol did not inhibit arthritis and joint destruction. Combination treatment with ibandronate and eldecalcitol may be effective for secondary osteoporosis associated with arthritis.</p>
-
Kasukawa Y.
Clinical Interventions in Aging ( Clinical Interventions in Aging ) 14 1399 - 1405 2019年
-
Kasukawa Y.
Asian Spine Journal ( Asian Spine Journal ) 13 ( 5 ) 832 - 841 2019年
-
Akagawa M.
PLoS ONE ( PLoS ONE ) 13 ( 10 ) 2018年10月
-
Kasukawa Y.
Pain Practice ( Pain Practice ) 18 ( 5 ) 625 - 630 2018年06月
-
Analgesic effects of minodronate in a rat chronic pain model
Kasukawa Y.
Biomedical Research (Japan) ( Biomedical Research (Japan) ) 39 ( 5 ) 261 - 268 2018年
<p>We evaluated the analgesic effects of minodronate, alendronate and pregabalin on mechanical and thermal allodynia, as well as changes in bone mineral density and skeletal muscle volume caused by chronic constriction injury (CCI) in an ovariectomized rat. Ovariectomy was performed on four-week-old female Wistar rats. Thereafter, at 8-weeks of age, the left sciatic nerve was ligated to create the chronic pain model (CCI limb), and sham surgery was performed on the right hindlimb. In all rats, either minodronate (0.15 mg/kg/week), alendronate (0.15 mg/kg/week), pregabalin (10 mg/kg/week), or their vehicle was administered for 2 weeks starting on the 0th day of CCI. Behavioral evaluations, with von Frey testing and the hot plate test, were performed on days 0, 7 and 14. After 2 weeks, bilateral femurs and tibialis anterior muscles were harvested for bone mineral density and cross sectional area measurements, respectively. Two weeks treatment with minodronate significantly improved mechanical and thermal allodynia evaluated by the von Frey and hot plate tests in the CCI limb (<i>P</i> < 0.05). Minodronate and alendronate treatment for 2 weeks significantly increased total femoral bone mineral density in the CCI limb compared with pregabalin or vehicle treatment (<i>P</i> < 0.01). Cross sectional area of the CCI limb in the minodronate group was significantly larger than that of the alendronate group (<i>P</i> < 0.05) and pregabalin group (<i>P</i> < 0.05). Two-week treatment with minodronate, but not alendronate or pregabalin, improved mechanical and thermal allodynia caused by CCI in ovariectomized rats.</p>
-
経験と考察 痙縮に対するボツリヌス毒素治療後の小児足部変形の手術成績
尾野 祐一, 坂本 仁, 三澤 晶子, 石原 芳人, 遠藤 博之, 島田 洋一
整形外科 ( 南江堂 ) 68 ( 12 ) 1259 - 1262 2017年11月
-
Age-related changes in muscle strength and spinal kyphosis angles in an elderly Japanese population
Kasukawa Y.
Clinical Interventions in Aging ( Clinical Interventions in Aging ) 12 413 - 420 2017年02月